The Exopulse Mollii Suit: Neuromodulation for Fibromyalgia
Start unlocking your patient's energy.
An innovative new approach to managing fibromyalgia
With this complex condition, clinical success takes treatment tailored to each patient’s unique needs. Consistent, effective relief often starts with the right combination of complementary treatments.
Now, there’s a groundbreaking new addition to your patients’ options: the Exopulse Mollii Suit, a wearable neuromodulation device that can help relieve fibromyalgia symptoms almost anywhere they occur.
Deliver clinically proven relief that increases over time.
Studies agree: The Suit offers a new and effective way to manage symptoms across the fibromyalgia syndrome [1,2], with outcomes demonstrated by a randomized, double-blind, sham-controlled clinical trial. [1]
What’s more, it offers relief that keeps increasing with regular use – including significant alleviation in 2 weeks and further improvement after 4 weeks. [1]
Reduced pain
14% reduction in 2 weeks (p<0.05), 25% reduction after 4 weeks (p<0.001) [1]
14% reduction in 2 weeks (p<0.05), 25% reduction after 4 weeks (p<0.001) [1]
Reduced fatigue
17% reduction in 2 weeks (p<0.05), 20% reduction after 4 weeks (p<0.001) [1]
17% reduction in 2 weeks (p<0.05), 20% reduction after 4 weeks (p<0.001) [1]
Enhanced energy-related quality of life
47% improvement in 2 weeks (p<0.01), 54% improvement after 4 weeks (p<0.001) [1]
47% improvement in 2 weeks (p<0.01), 54% improvement after 4 weeks (p<0.001) [1]
60 minutes
Some patients reported feeling significantly less fibromyalgia-related pain after a single one-hour session in the Suit. [2]
2 weeks
After 14 daily sessions, nearly 2 out of 3 patients (64%) demonstrated improvement in global clinical impression. [1]
4 weeks
After one month of daily stimulation, global clinical impression improved for nearly 4 out of 5 patients (78%). [1]
Near-full body stimulation for fibromyalgia symptoms
The Suit is a new step forward in neuromodulation for fibromyalgia. With its innovative design and functionality, it turns a trusted pain management method into a comprehensive approach to managing fibromyalgia symptoms — almost anywhere your patients may experience them.
What is the Suit?
The Suit is an assistive neuromodulation device that consists of a jacket and pants. Both contain a total of 58 embedded electrodes that can deliver customizable stimulation nearly anywhere in the body.
This individualized approach has been shown to significantly improve fibromyalgia-related pain and fatigue, as well as patients’ energy-related quality of life. [1]
Add a tailored, targeted treatment to patients’ care.
Every patient has their own unique experience with fibromyalgia. The Suit provides an adaptable, patient-friendly way to individualize their treatment and target their symptoms — all while safely continuing other trusted treatments.
Customizable stimulation
The Suit is equipped with 58 embedded electrodes that can stimulate muscle groups throughout the body. The stimulation pattern can be adapted to individual patient needs.
The Suit is equipped with 58 embedded electrodes that can stimulate muscle groups throughout the body. The stimulation pattern can be adapted to individual patient needs.
Complementary care
The Suit can be used alongside existing treatments for fibromyalgia.
The Suit can be used alongside existing treatments for fibromyalgia.
Non-invasive approach
Unlike some neuromodulation devices, the Suit requires no uncomfortable, invasive implantation procedures. To begin treatment, patients simply slip on the garments and hit “start.”
Unlike some neuromodulation devices, the Suit requires no uncomfortable, invasive implantation procedures. To begin treatment, patients simply slip on the garments and hit “start.”
Relieve physical and psychological symptoms.
For many fibromyalgia patients, chronic pain can have a big impact on mental health too. With consistent use, the Suit can help address many psychological symptoms too.
In fact, after 4 weeks of daily stimulation, patients report both increasing alleviation of pain and fatigue and improvement in depression and anxiety. [1]
Help patients manage fibromyalgia at home.
Once patients have been trained to use the Suit, they can take it home and get their everyday treatment whenever it’s convenient for them.
A daily hour in the Suit can help your patients to alleviate fibromyalgia symptoms. [1]
See how the Suit helped Elisa reenergize.
Patients with fibromyalgia are already discovering how the Suit can help them improve their symptoms.
Just ask Elisa. Now that she’s added the Suit to her fibromyalgia treatment, she feels exactly how she wants to: like Elisa.
Three key times to assess your patients’ results
Fibromyalgia’s unpredictable presentation and symptoms can make it hard to identify optimal times to evaluate treatment response. But with the Suit, clear clinical evidence can help guide you.
Based on documented outcomes, patients’ response to the Suit is typically identifiable at three important time points:
- After 60 minutes, check for the rapid onset of pain relief reported by some users. [2] Patients may only experience significant results after 2 or 4 weeks of daily 60 minutes usage. [1]
- After 14 daily sessions, check for significant alleviation of pain, reduction in fatigue, and improvement in energy-related quality of life. [1]
- After 4 weeks, check for further improvement in pain, fatigue, and energy-related quality of life – as well as reduced depression and anxiety. [1]
More important information for healthcare professionals
Evaluate the Suit in your clinic.
Ready for a hands-on evaluation of the Suit’s design, technology, and functionality? Contact our team of neuromodulation experts to schedule a virtual demo or in-person training.
References: 1. Ayache S. A Multisite Stimulation Approach on Motor Functions and Pain in Multiple Sclerosis (MS) and Fibromyalgia - the French Experience. Presented at: OTWorld; 14 May 2024; Leipzig, Germany. 2. Riachi N, Chalah MA, Ahdab R, Arshad F, Ayache SS. Effects of the TENS device, Exopulse Mollii Suit, on pain related to fibromyalgia: An open-label study. Neurophysiol Clin. 2023 Aug;53(4):102863.
*The testimonials, statements, and opinions presented in the videos are only applicable to the individuals depicted. The testimonials are not representative of patient experience. The exact results and experience will be unique and individual to each patient. The users depicted in the videos received compensation for the time spent on filming with Ottobock.
Notification: The information contained in this document is only intended for an audience outside the United States. Please note that the products described here are not FDA approved. Not all products and services are registered or available for sale in all countries.